1st Quarter - Report

MEHLMAN CONSULTING, INC. for ABBOTT LABORATORIES

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care reform; Food & Drug Administration reforms. H.R.1, The American Recovery and Reinvestment Act H.R.2, The Children's Health Insurance Program Extension H.Con.Res.85, House Budget Resolution and S.Con.Res.13, Senate Budget Resolution

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Con.Res. 85 (111th), H.R. 1 (111th), H.R. 2 (111th), S.Con.Res. 13 (111th)

Trade (domestic/foreign) TRD

Health care reform; Food & Drug Administration reforms; Medicare coverage and reimbursement.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Health care reform; Food & Drug Administration reforms; Medicare coverage and reimbursement.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Health care reform; Food & Drug Administration reforms; Medicare coverage and reimbursement. Deferral: Repatriation H.R.1, The American Recovery and Reinvestment Act.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (111th)

Medicare/Medicaid MMM

Health care reform; Medicare Coverage and reimbursement for end-stage renal disease. H.R.2, The Children's Health Insurance Program Extension H.Con.Res.85, House Budget Resolution and S.Con.Res.13, Senate Budget Resolution

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 13 (111th), H.Con.Res. 85 (111th), H.R. 2 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.